Literature DB >> 3192041

Uricase protein sequences: conserved during vertebrate evolution but absent in humans.

A Varela-Echavarría1, R Montes de Oca-Luna, H A Barrera-Saldaña.   

Abstract

Uricase is a peroxisomal liver enzyme that catalyzes the oxidation of uric acid to allantoin during purine catabolism. It is present in vertebrates in most species of fish, amphibians, and mammals but its enzymatic activity is absent in hominoids. We have used Western blot analysis in a comparative study to establish a homology among uricases from different species of vertebrates. Using antibodies against denatured rat liver uricase, we have been able to detect for the first time cross-reactivity with the uricase of species ranging in the evolutionary scale from fish to primates (macaque). Our results suggest that these uricases have a common evolutionary origin. Our conclusion is also supported by the fact that uricase from different species exhibits identical tissue, subcellular localization, and similarity of molecular weights. This study was extended to include human liver samples. Using the same approach but with a more sensitive detection system (alkaline phosphatase instead of peroxidase), we did not detect polypeptide species related to rat uricase in human fetal or adult liver samples, which indicates that during hominoid evolution, the mutational event responsible for the loss of uricase activity in humans precluded formation of a translatable uricase mRNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192041     DOI: 10.1096/fasebj.2.15.3192041

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.

Authors:  Mahmoud A Ghannoum; Pranab K Mukherjee; Richard J Jurevic; Mauricio Retuerto; Robert E Brown; Masoumeh Sikaroodi; Jennifer Webster-Cyriaque; Patrick M Gillevet
Journal:  OMICS       Date:  2011-07-13

Review 2.  Difficult-to-treat gouty arthritis: a disease warranting better management.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

3.  Uric acid enhances longevity and endurance and protects the brain against ischemia.

Authors:  Roy G Cutler; Simonetta Camandola; Neil H Feldman; Jeong Seon Yoon; James B Haran; Sandro Arguelles; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2018-12-12       Impact factor: 4.673

4.  Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Theodora Szasz; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

Review 5.  New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.

Authors:  Naomi Schlesinger
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

6.  Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.

Authors:  Michael R Wiederkehr; Orson W Moe
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

7.  Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.

Authors:  Gwen S Scott; Sergei V Spitsin; Rhonda B Kean; Tatiana Mikheeva; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

8.  An animal model for measuring the effect of common NICU procedures on ATP metabolism.

Authors:  Megan S Plank; Danilo S Boskovic; Edward Tagge; John Chrisler; Laurel Slater; Katherine R Angeles; Danilyn M Angeles
Journal:  Biol Res Nurs       Date:  2011-03-15       Impact factor: 2.522

9.  Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.

Authors:  C J Danpure; P E Purdue; P Fryer; S Griffiths; J Allsop; M J Lumb; K M Guttridge; P R Jennings; J I Scheinman; S M Mauer
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

10.  Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Authors:  Marzena J Fabis; Timothy W Phares; Rhonda B Kean; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.